Luca Tordella
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Journal: Nature
Published: July 02, 2025
Identification and characterization of binders to a cryptic and functional pocket in KRAS.
Journal: Nature communications
Published: October 29, 2024
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Journal: Nature communications
Published: August 19, 2024
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Journal: Nature cancer
Published: June 17, 2024
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Journal: Nature cancer
Published: May 22, 2023
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Journal: Nature communications
Published: May 12, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer.
Journal: Cancer research
Published: April 14, 2023
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms.
Journal: ACS pharmacology & translational science
Published: November 15, 2020
PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma.
Journal: Nature communications
Published: October 12, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026